india glp-1 🚀 The Generic Revolution: India's $1B Opportunity March 20, 2026 marked a watershed moment—semaglutide's patent expiry unleashed 50+ generic launches in India. Within days, prices crashed 70-90%: ₹1,290/vial (Natco) vs ₹4,200+ ( India's GLP-1 Opportunity: Why Startups
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8





-webp.webp?width=1920&height=1281&name=Culver%20City%20Treatment%20room%20(1)-webp.webp)






















